A study to determine safety and effectiveness of Syrup Urophyll in patients of chronic kidney disease.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Chronic Kidney Disease
- Registration Number
- CTRI/2017/06/008870
- Lead Sponsor
- Thinq Pharma CRO Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Known case of chronic kidney disease aged between 18 and 70 years
2.Written informed consent
3.Serum Creatinine is at least 1.8 mg/dL at the time of screening
4.Blood pressure and blood sugar that is well controlled in the last one year
Exclusion Criteria
1.Patients who has had episode(s) of dialysis in last 6 months
2.History of kidney transplant
3.Pregnant or breast-feeding woman
4.Nephrotic syndrome
5.Patients with uncontrolled diabetes, hypertension, gout or other illness
6.Participant of other clinical trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum CreatinineTimepoint: 2 and 3 months post enrollment
- Secondary Outcome Measures
Name Time Method Sr. Urea, Hemoglobin, Quality of LifeTimepoint: 2 and 3 months post enrollment